EXTON, PA, September 26, 2024 – Ricoh USA, Inc. and Kallisio today announced a strategic partnership to manufacture and distribute Stentra™, a 510(k)-cleared, patient-specific oral stent designed to improve radiation therapy for head and neck cancer (HNC) patients. Developed using technology exclusively licensed from MD Anderson Cancer Center, Stentra™ is engineered to protect healthy tissue by precisely displacing and...
The post RICOH 3D for Healthcare and Kallisio Partner to Enhance Radiation Oncology Care with Stentra™ Oral Stent appeared first on Industry Analysts, Inc..
More...
The post RICOH 3D for Healthcare and Kallisio Partner to Enhance Radiation Oncology Care with Stentra™ Oral Stent appeared first on Industry Analysts, Inc..
More...